182 related articles for article (PubMed ID: 10954310)
21. Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.
Komura K; Inamoto T; Masuda H; Watsuji T; Azuma H
Acta Biomed; 2012 Dec; 83(3):189-96. PubMed ID: 23762994
[TBL] [Abstract][Full Text] [Related]
22. [Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound].
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Souchon R; Blanc E; Cathignol D; Dubernard JM
Prog Urol; 1998 Feb; 8(1):68-77. PubMed ID: 9533155
[TBL] [Abstract][Full Text] [Related]
23. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
[TBL] [Abstract][Full Text] [Related]
24. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
25. Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.
Blana A; Robertson CN; Brown SC; Chaussy C; Crouzet S; Gelet A; Conti GN; Ganzer R; Pasticier G; Thuroff S; Ward JF
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):256-9. PubMed ID: 22487909
[TBL] [Abstract][Full Text] [Related]
26. Treatment of localized prostate cancer using high-intensity focused ultrasound.
Uchida T; Ohkusa H; Nagata Y; Hyodo T; Satoh T; Irie A
BJU Int; 2006 Jan; 97(1):56-61. PubMed ID: 16336329
[TBL] [Abstract][Full Text] [Related]
27. [The correlation of PSA-nadir PS recurrence after total HIFU-ablation in patients with localized prostate cancer].
Fomkin RN; Krupinov GE; Churakov AA; Shatylko TV; Fomkina OA; Zhmakin VA
Urologiia; 2020 Sep; (4):79-83. PubMed ID: 32897659
[TBL] [Abstract][Full Text] [Related]
28. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.
Ficarra V; Antoniolli SZ; Novara G; Parisi A; Fracalanza S; Martignoni G; Artibani W
BJU Int; 2006 Dec; 98(6):1193-8. PubMed ID: 17125477
[TBL] [Abstract][Full Text] [Related]
29. Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue.
Ryan P; Finelli A; Lawrentschuk N; Fleshner N; Sweet J; Cheung C; van der Kwast T; Evans A
J Clin Pathol; 2012 Aug; 65(8):729-34. PubMed ID: 22659332
[TBL] [Abstract][Full Text] [Related]
30. [High-intensity focused ultrasound (HIFU) for the prostate cancer treatment: 5-year resuts].
Shaplysin LV; Solov VA; Vosdvizhenskiĭ MO; Khametov RZ
Urologiia; 2013; (1):70-2. PubMed ID: 23662500
[TBL] [Abstract][Full Text] [Related]
31. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
32. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
33. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
[TBL] [Abstract][Full Text] [Related]
34. High-intensity focused ultrasound (HIFU) in prostate cancer: a single centre experience in patients with low, intermediate or high-risk of progression.
Callea A; Piccinni R; Zizzi V; Sblendorio D; Berardi B; Tempesta A; Gala FG; Traficante A
Arch Ital Urol Androl; 2010 Dec; 82(4):253-5. PubMed ID: 21341574
[TBL] [Abstract][Full Text] [Related]
35. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
[TBL] [Abstract][Full Text] [Related]
36. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
37. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer.
Uchida T; Ohkusa H; Yamashita H; Shoji S; Nagata Y; Hyodo T; Satoh T
Int J Urol; 2006 Mar; 13(3):228-33. PubMed ID: 16643614
[TBL] [Abstract][Full Text] [Related]
38. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
[TBL] [Abstract][Full Text] [Related]
39. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer.
Rebillard X; Gelet A; Davin JL; Soulie M; Prapotnich D; Cathelineau X; Rozet F; Vallancien G
J Endourol; 2005; 19(6):693-701. PubMed ID: 16053358
[TBL] [Abstract][Full Text] [Related]
40. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience.
Gelet A; Chapelon JY; Bouvier R; Souchon R; Pangaud C; Abdelrahim AF; Cathignol D; Dubernard JM
Eur Urol; 1996; 29(2):174-83. PubMed ID: 8647143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
